Latin American Symposium on Gastrointestinal Oncology (SLAGO) 2013

Dr Christian Caglevic - Fundación Arturo López Pérez, Santiago, Chile
Latin American Symposium on Gastrointestinal Oncology (SLAGO) 2013 ( Dr Christian Caglevic - Fundación Arturo López Pérez, Santiago, Chile )
25 Jul 2013

Epidemiology of gastric cancer in Latin America

Dr Eduardo Cazap - SLACOM, Buenos Aires, Argentina
Epidemiology of gastric cancer in Latin America ( Dr Eduardo Cazap - SLACOM, Buenos Aires, Argentina )
25 Jul 2013

Strategies to address inter- and intra- patient tumour heterogeneity: PANGEA

Dr Daniel Catenacci - University of Chicago, Chicago, USA
Strategies to address inter- and intra- patient tumour heterogeneity: PANGEA ( Dr Daniel Catenacci - University of Chicago, Chicago, USA )
19 Jul 2013

Identifying and applying molecular subgrouping in colorectal cancer

Dr Sabine Tejpar - University of Leuven, Leuven, Belgium
Identifying and applying molecular subgrouping in colorectal cancer ( Dr Sabine Tejpar - University of Leuven, Leuven, Belgium )
18 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013

Next generation of anti-cancer agents: data from ASCO 2013

Dr Sarah Blagden - Imperial College, London, UK
Next generation of anti-cancer agents: data from ASCO 2013 ( Dr Sarah Blagden - Imperial College, London, UK )
4 Jun 2013

Bevacizumab extends survival for relapsed and advanced cervical cancer

Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA
Bevacizumab extends survival for relapsed and advanced cervical cancer ( Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA )
2 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volke Heinemann - University of Munich Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volke Heinemann - University of Munich Munich, Germany )
1 Jun 2013

Cetuximab superior to bevacizumab for advanced colorectal cancer

Dr Volker Heinemann - University of Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volker Heinemann - University of Munich, Germany )
1 Jun 2013

Racial disparities in cancer outcomes

Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA
Racial disparities in cancer outcomes ( Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA )
19 Apr 2013